Form 4: Inari Medical Director William Hoffman Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Director William Hoffman of Inari Medical, Inc. executed sales of common stock on October 16, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- William Hoffman, a director at Inari Medical, Inc., sold shares of common stock on October 16, 2024.
- The sales were executed under a Rule 10b5-1 trading plan adopted on December 14, 2023.
- A total of 27,804 shares were sold at a weighted average price of $44.78, and 12,196 shares were sold at a weighted average price of $45.57.
- Following these transactions, Hoffman directly owns 601,233 shares of Inari Medical, Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating insider trading activity. The sentiment is neutral as it simply reports transactions without expressing any opinion on the company's performance or future prospects.
Industry Context
Sales by insiders are a common occurrence and are often related to personal financial planning rather than a reflection of the company's prospects.
Stakeholder Impact
- The stock sale by a director could potentially create short-term negative sentiment among shareholders.
Key Dates
| Date | Description |
|---|---|
| December 14, 2023 | Date of adoption of the Rule 10b5-1 trading plan. |
| October 16, 2024 | Date of the stock sale transactions. |
| October 18, 2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.